Intact Vascular has raised $10 million in a new mixed round of financing, according to an SEC filing posted this week.
Money in the round comes from 3 anonymous investors, with the first sale noted on April 5, according to the filing.
The company has not yet officially stated how it plans to spend the funds, but noted that $2.1 million of the proceeds will be used to pay its executive officers, directors or promoters.
Intact Vascular is looking for an additional $11.8 million in the round to close out at $21.8 million, according to the filing.
Last July, Intact Vascular announced the European launch of the Toba II BTK clinical trial of its Tack endovascular system in combination with standard balloon angioplasty in the popliteal and tibial arteries for treating critical limb ischemia.